首页> 外文OA文献 >Azithromycin added to Hydroxychloroquine in Patients Admitted to Intensive Care due to Coronavirus Disease 2019 (COVID-19) – Protocol of Randomized Controlled Trial AZIQUINE-ICU

【2h】

Azithromycin added to Hydroxychloroquine in Patients Admitted to Intensive Care due to Coronavirus Disease 2019 (COVID-19) – Protocol of Randomized Controlled Trial AZIQUINE-ICU

机译：由于冠状病毒疾病（Covid-19） - 随机对照试验的协议，加入到羟基氯喹（Coronavirus疾病）中加入羟基氯喹蛋白 - 随机对照试验的协议 - ICU

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
František Duška; Petr Waldauf; Milada Halačová; Václav Zvoníček; Jakub Bala; Martin Balík; Jan Beneš; Olga Klementová; Irena Kozáková; Viktor Kubricht; Anne Le Roy; Tomáš Vymazal; Veronika Řehořová; Vladimír Černý;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU [J] . Franti?ek Du?ka, Petr Waldauf, Milada Hala?ová, Trials . 2020,第1期

机译：由于冠状病毒疾病2019（Covid-19） - 随机对照试验的协议，添加到羟基氯喹蛋白，用于患有重症监护的患者 - 随机对照试验Aziquine-ICU
2. Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial [J] . Javed Akram, Shehnoor Azhar, Muhammad Shahzad, Trials . 2020,第1期

机译：巴基斯坦随机和观察试验评估羟氯喹，奥司他韦和阿奇霉素的冠状病毒治疗（保护）治疗新诊断的Covid-19感染患者，他们没有糖尿病等糖尿病：随机对照试验的研究方案的结构化概述
3. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial [J] . Miguel Rodríguez-Rubio, Juan Carlos Figueira, Darío Acu?a-Castroviejo, Trials . 2020,第1期

机译：II期，单中心，双盲，随机安慰剂对照试验，用于探讨静脉内褪黑激素在Covid-19患者中录取重症监护单元（Melcovid研究）的疗效和安全性：研究方案的结构化概述对于随机对照试验
4. 2019 Novel Coronavirus Disease (Covid-19): Toward a Novel Design for Disinfection Robot to Combat Coronavirus (Covid-19) Using IoT Based Technology [C] . M. N. Mohammed, Nurul Aslamiah Hazairin, Arif Sameh Arif, IEEE Control and System Graduate Research Colloquium . 2021

机译：2019年新型冠状病毒病（Covid-19）：朝着使用基于机器的技术的消毒机器人的新设计，用于打击冠状病毒（Covid-19）
5. The Effects of the Coronavirus Disease 2019 (COVID-19) on G7 Financial Markets [D] . Elatraby, Karim. 2021

机译：冠状病毒疾病2019（Covid-19）对G7金融市场的影响
6. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU [O] . František Duška, Petr Waldauf, Milada Halačová, -1

机译：阿奇霉素被添加到羟氯喹中用于因冠状病毒病2019（COVID-19）而接受重症监护的患者-随机对照试验AZIQUINE-ICU的协议
7. Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial [O] . Javed Akram, Shehnoor Azhar, Muhammad Shahzad, 2020

机译：矫正：巴基斯坦随机和观测试验评估羟氯喹，奥司他韦和阿奇霉素的冠状病毒治疗（保护）治疗新诊断的Covid-19感染患者：随机对照试验的研究方案的结构化概述

Azithromycin added to Hydroxychloroquine in Patients Admitted to Intensive Care due to Coronavirus Disease 2019 (COVID-19) – Protocol of Randomized Controlled Trial AZIQUINE-ICU

著录项

引文网络

相似文献

相关主题

期刊订阅